Skip to main content

Chuck Triano

Head of Investor Relations

Bristol Myers Squibb Co (BMY)

Head of Investor Relations

Pfizer Inc (PFE)

Head of Investor Relations

Biogen Inc. (BIIB)

Equibles does not estimate personal net worth.

Get an email with a short summary when Bristol Myers Squibb Co publishes a filing, an earnings call transcript or a press release.

Get BMY alerts

About Chuck Triano

Chuck Triano is recorded as Head of Investor Relations at Bristol Myers Squibb Co (BMY), Head of Investor Relations at Pfizer Inc (PFE) and Head of Investor Relations at Biogen Inc. (BIIB). Chuck Triano has spoken on 16 earnings calls across 3 companies, most recently for Bristol Myers Squibb Co on October 29, 2026. Those appearances were for Bristol Myers Squibb Co (BMY), Biogen Inc. (BIIB) and Pfizer Inc (PFE). Bristol Myers Squibb Co is classified in the Drug Manufacturers - General industry within the Healthcare sector. Biogen Inc. is classified in the Drug Manufacturers - General industry within the Healthcare sector. Other leadership on record at Bristol Myers Squibb Co includes Christopher Boerner (CEO, COO and Board Member), Christopher Boerner, Ph.D. (CEO, COO and Board Member), David Elkins (CFO) and 6 others.

Chuck Triano on recent calls

“We appreciate you joining our third quarter 2026 earnings call. With me this morning with prepared remarks are Chris Berner, our Board Chair and Chief Executive Officer, and David Elkins, our Chief Financial Officer.”
Head of Investor Relations, Bristol Myers Squibb Q3 2026 Results Conference Call ·
“We appreciate you joining our second quarter 2026 earnings call. With me this morning with prepared remarks are Chris Berner, our Board Chair and Chief Executive Officer, and David Elkins, our Chief Financial Officer.”
Head of Investor Relations, Bristol Myers Squibb Q2 2026 Results Conference Call ·
“We appreciate you joining our fourth quarter 2025 earnings call. With me this morning with prepared remarks are Chris Berner, our Board Chair and Chief Executive Officer, and David Elkins, our Chief Financial Officer.”
Head of Investor Relations, Bristol Myers Squibb Co Q4 FY2025 Earnings Call ·
“We appreciate you joining our third quarter 2025 earnings call. With me this morning with prepared remarks are Chris Boerner, our Board Chair and Chief Executive Officer; and David Elkins, our Chief Financial Officer.”
Head of Investor Relations, Bristol Myers Squibb Co Q3 FY2025 Earnings Call ·

Affiliation history

Company network

Leadership on record at Bristol Myers Squibb Co

Leadership on record at Biogen Inc.

Leadership on record at Pfizer Inc

Recent activity